Summary
In 2024, U.S. drug overdose deaths saw a historic decline of 30,000, totaling approximately 80,000, marking a 27% drop from 2023, though rates remain elevated compared to pre-pandemic levels. Factors contributing to this decline include increased access to naloxone, expanded addiction treatment, and significant funding from opioid lawsuit settlements. Experts caution that federal funding cuts and a focus on law enforcement rather than public health could hinder progress, emphasizing the need for sustained efforts to combat the ongoing overdose crisis.
